A new fund named as “COVID-19 Therapeutics Accelerator” has been launched by the Bill & Melinda Gates Foundation, Wellcome and Mastercard. The $125 Million fund has been launched to accelerate technologies to fight against the COVID-19 epidemic.
About “COVID-19 Therapeutics Accelerator”:
“COVID-19 Therapeutics Accelerator” fund has been designed to identify, assess, develop and scale treatments to the COVID-19 disease outbreak. The fund aims to assess new and repurposed drugs and biologics to cure patients suffering from COVID-19 in the immediate term, and also capable of curing other viral pathogens in the future.
The COVID-19 Therapeutics Accelerator will also work along the World Health Organization, government and private sector funders and various other organizations as well as regulators and policy-setting institutions.